-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Aclaris Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2015 to Q2 2025.
- Aclaris Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2025 was $2.98M, a 59.5% increase year-over-year.
- Aclaris Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2025 was $12M.
- Aclaris Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $9.87M, a 16% increase from 2023.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)